M. H. Mark

2.3k total citations
16 papers, 1.5k citations indexed

About

M. H. Mark is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, M. H. Mark has authored 16 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Neurology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Physiology. Recurrent topics in M. H. Mark's work include Parkinson's Disease Mechanisms and Treatments (11 papers), Neurological disorders and treatments (5 papers) and Alzheimer's disease research and treatments (3 papers). M. H. Mark is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (11 papers), Neurological disorders and treatments (5 papers) and Alzheimer's disease research and treatments (3 papers). M. H. Mark collaborates with scholars based in United States, United Kingdom and Netherlands. M. H. Mark's co-authors include Matthew Menza, Dennis W. Dickson, Roger C. Duvoisin, S. -H. Yen, David J. Brooks, David J. Burn, J. I. Sage, Allison Dicke, Humberto Marín and Steven Buyske and has published in prestigious journals such as Neurology, Annals of Neurology and American Journal Of Pathology.

In The Last Decade

M. H. Mark

16 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. H. Mark United States 14 1.3k 525 351 311 170 16 1.5k
Cliff Shults United States 11 996 0.8× 410 0.8× 235 0.7× 245 0.8× 181 1.1× 12 1.4k
Antony J. Harding Australia 15 653 0.5× 319 0.6× 214 0.6× 444 1.4× 214 1.3× 22 1.3k
T. Caraceni Italy 26 1.3k 1.0× 714 1.4× 188 0.5× 121 0.4× 183 1.1× 90 1.8k
E.M.J. Foncke Netherlands 26 1.3k 1.1× 568 1.1× 180 0.5× 133 0.4× 182 1.1× 45 1.7k
Heidi Cartwright Australia 15 976 0.8× 659 1.3× 249 0.7× 258 0.8× 108 0.6× 17 1.5k
Roberto Marconi Italy 18 922 0.7× 400 0.8× 202 0.6× 236 0.8× 706 4.2× 29 1.8k
Franck Durif France 22 1.2k 0.9× 524 1.0× 230 0.7× 140 0.5× 83 0.5× 69 1.5k
Elena Torre Italy 17 799 0.6× 248 0.5× 269 0.8× 144 0.5× 165 1.0× 21 1.2k
Sophie Winder‐Rhodes United Kingdom 12 1.0k 0.8× 315 0.6× 178 0.5× 537 1.7× 237 1.4× 13 1.5k
B. Alfaro United States 11 1.1k 0.8× 331 0.6× 148 0.4× 221 0.7× 243 1.4× 12 1.3k

Countries citing papers authored by M. H. Mark

Since Specialization
Citations

This map shows the geographic impact of M. H. Mark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. H. Mark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. H. Mark more than expected).

Fields of papers citing papers by M. H. Mark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. H. Mark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. H. Mark. The network helps show where M. H. Mark may publish in the future.

Co-authorship network of co-authors of M. H. Mark

This figure shows the co-authorship network connecting the top 25 collaborators of M. H. Mark. A scholar is included among the top collaborators of M. H. Mark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. H. Mark. M. H. Mark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Menza, Matthew, Roseanne D. Dobkin, Humberto Marín, et al.. (2008). A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology. 72(10). 886–892. 277 indexed citations
2.
Dickson, Dennis W., John Hardy, Matthew J. Farrer, et al.. (1999). Widespread Alterations of α-Synuclein in Multiple System Atrophy. American Journal Of Pathology. 155(4). 1241–1251. 254 indexed citations
3.
Piccini, Paola, Paul Morrish, N. Turjanski, et al.. (1997). Dopaminergic function in familial Parkinson's disease: A clinical and 18F‐dopa positron emission tomography study. Annals of Neurology. 41(2). 222–229. 100 indexed citations
4.
Golbe, Lawrence I., Jerry M. Belsh, Roger C. Duvoisin, et al.. (1996). Follow-up study of risk factors in progressive supranuclear palsy. Neurology. 47(1). 148–154. 46 indexed citations
5.
Mark, M. H., et al.. (1996). The clinicopathologic spectrum of Lewy body disease.. PubMed. 69. 315–8. 13 indexed citations
6.
Herz, M I, et al.. (1996). Improving the professional self-efficacy cognitions of immigrant doctors with Balint groups.. PubMed. 33(4). 253–9. 10 indexed citations
7.
Mark, M. H., J. I. Sage, Arthur S. Walters, Roger C. Duvoisin, & D. Craig Miller. (1995). Binswanger's disease presenting as levodopa‐responsive parkinsonism: Clinicopathologic study of three cases. Movement Disorders. 10(4). 450–454. 56 indexed citations
8.
Menza, Matthew, M. H. Mark, David J. Burn, & David J. Brooks. (1995). Personality correlates of [18F]dopa striatal uptake: results of positron-emission tomography in Parkinson's disease. Journal of Neuropsychiatry. 7(2). 176–179. 62 indexed citations
9.
Mark, M. H., Dennis W. Dickson, Richard E. Heikkila, et al.. (1994). Meige syndrome in the spectrum of Lewy body disease. Neurology. 44(8). 1432–1432. 29 indexed citations
10.
Menza, Matthew & M. H. Mark. (1994). Parkinson's disease and depression: the relationship to disability and personality. Journal of Neuropsychiatry. 6(2). 165–169. 83 indexed citations
11.
Lazzarini, Alice, Richard H. Myers, Thomas Zimmerman, et al.. (1994). A clinical genetic study of Parkinson's disease. Neurology. 44(3_part_1). 499–499. 106 indexed citations
12.
Mark, M. H., J. I. Sage, Dennis W. Dickson, Kirsten Schwarz, & Roger C. Duvoisin. (1992). Levodopa‐nonresponsive Lewy body parkinsonism. Neurology. 42(7). 1323–1323. 32 indexed citations
13.
Burn, David J., M. H. Mark, E. Diane Playford, et al.. (1992). Parkinson's disease in twins studied with 18 F‐dopa and positron emission tomography. Neurology. 42(10). 1894–1894. 153 indexed citations
14.
Sage, J. I., M. H. Mark, Denise M. McHale, Patricia K. Sonsalla, & Donata Vitagliano. (1991). Benefits of monitoring plasma levodopa in Parkinson's disease patients with drug‐induced chorea. Annals of Neurology. 29(6). 623–628. 18 indexed citations
15.
Dickson, Dennis W., Howard Crystal, M. H. Mark, et al.. (1991). Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease. Neurology. 41(9). 1402–1402. 227 indexed citations
16.
Mark, M. H. & Peter Farmer. (1982). THE SEARCH FOR THE HUMAN SUBFORNICAL ORGAN. Journal of Neuropathology & Experimental Neurology. 41(3). 346–346. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026